Donald Trump has announced a deal with several large pharmaceutical firms, including Switzerland’s Novartis and Genentech, a subsidiary of Roche, reported SRF. The agreement, unveiled at the White House, is intended to lower the prices of selected medicines in the United States and to allow drugmakers to sell them directly to consumers online.
In exchange, participating companies will receive three years of duty-free treatment for imported pharmaceuticals. Executives from several firms attended…
